share_log

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lurker Nancy

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lurker Nancy

EyePoint Pharmaceuticals | 4：持股變動聲明-董事 Lurker Nancy
美股SEC公告 ·  07/27 04:49
牛牛AI助理已提取核心訊息
EyePoint Pharmaceuticals, Inc. (EYPT) has reported a transaction involving Nancy Lurker, a person associated with the company. The transaction, which took place on July 26, 2024, did not specify the relationship of Nancy Lurker to the issuer. Details regarding the number of shares, nature of the shares, transaction price, and post-transaction holdings were not disclosed in the announcement.
EyePoint Pharmaceuticals, Inc. (EYPT) has reported a transaction involving Nancy Lurker, a person associated with the company. The transaction, which took place on July 26, 2024, did not specify the relationship of Nancy Lurker to the issuer. Details regarding the number of shares, nature of the shares, transaction price, and post-transaction holdings were not disclosed in the announcement.
EyePoint Pharmaceuticals, Inc.（EYPT）報道了涉及公司相關人員Nancy Lurker的一筆交易。該交易於2024年7月26日進行，未說明Nancy Lurker與發行人的關係。公告中未披露有關股份數量、股份性質、交易價格和交易後持股情況的細節。
EyePoint Pharmaceuticals, Inc.（EYPT）報道了涉及公司相關人員Nancy Lurker的一筆交易。該交易於2024年7月26日進行，未說明Nancy Lurker與發行人的關係。公告中未披露有關股份數量、股份性質、交易價格和交易後持股情況的細節。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間